Literature DB >> 22007944

Glucotoxicity and α cell dysfunction: involvement of the PI3K/Akt pathway in glucose-induced insulin resistance in rat islets and clonal αTC1-6 cells.

Xiao-Xia Shen1, Hong-Liang Li, Lin Pan, Jing Hong, Juan Xiao, Kjeld Hermansen, Per Bendix Jeppesen, Guang-Wei Li.   

Abstract

AIM/HYPOTHESIS: The objective of this study was to assess how long-term exposure to high glucose affects the α cell function and whether the increased glucagon secretion is mediated via insulin resistance.
MATERIALS AND METHODS: We established a β cell-depleted rat model to obtain pure primary α cells. Furthermore, isolated rat islets and TC1-6 cells (a clonal α cell line) were exposed to high glucose (25 or 30 mmol/L) and low glucose (5.5 mmol/L) for up to 5 days to evaluate the influence of chronic glucose toxicity on glucagon secretion and glucagon gene expression. Moreover, we added insulin and/or Wortmannin to examine if the inhibitory effect of insulin on glucagon secretion was impaired by high glucose via the phosphatidylinositol 3 kinase/PKB protein kinase B pathway.
RESULTS: Both glucagon secretion and glucagon gene expression were increased in response to 5 days exposure to high glucose. While a moderate insulin concentration slightly inhibits glucagon secretion from rat islets and α TC1-6 cells at high glucose, a pronounced increase in glucagon secretion was observed at low glucose. We found that the insulin-mediated activity of the phosphatidylinositol 3 kinase/PKB protein kinase B pathway in the α cell was markedly impaired by chronic exposure to high glucose.
CONCLUSION: The hypersecretion of glucagon induced by glucotoxicity may be secondary to insulin resistance of the α cell induced by impaired activity of the insulin signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22007944     DOI: 10.3109/07435800.2011.610855

Source DB:  PubMed          Journal:  Endocr Res        ISSN: 0743-5800            Impact factor:   1.720


  4 in total

1.  The effect of PPARγ agonist on SGLT2 and glucagon expressions in alpha cells under hyperglycemia.

Authors:  M Kim; E J Lee; H M Shin; H S Jung; T K Kim; T N Kim; M J Kwon; S H Lee; B D Rhee; J H Park
Journal:  J Endocrinol Invest       Date:  2017-04-08       Impact factor: 4.256

2.  α-Cell Dysfunctions and Molecular Alterations in Male Insulinopenic Diabetic Mice Are Not Completely Corrected by Insulin.

Authors:  Rodolphe Dusaulcy; Sandra Handgraaf; Mounia Heddad-Masson; Florian Visentin; Christian Vesin; Franck Reimann; Fiona Gribble; Jacques Philippe; Yvan Gosmain
Journal:  Endocrinology       Date:  2015-12-22       Impact factor: 4.736

3.  Insulin receptor substrate 1, but not IRS2, plays a dominant role in regulating pancreatic alpha cell function in mice.

Authors:  Tomozumi Takatani; Jun Shirakawa; Kimitaka Shibue; Manoj K Gupta; Hyunki Kim; Shusheng Lu; Jiang Hu; Morris F White; Robert T Kennedy; Rohit N Kulkarni
Journal:  J Biol Chem       Date:  2021-04-09       Impact factor: 5.157

4.  The microRNA-124-iGluR2/3 pathway regulates glucagon release from alpha cells.

Authors:  Haiyang Zhang; Rui Liu; Ting Deng; Xia Wang; Hongmei Lang; Yanjun Qu; Jingjing Duan; Dingzhi Huang; Guoguang Ying; Yi Ba
Journal:  Oncotarget       Date:  2016-04-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.